-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Eli Lilly, Raises Price Target to $1600

Benzinga·10/30/2026 15:50:02
Diffusion vocale
RBC Capital analyst Trung Huynh maintains Eli Lilly (NYSE:LLY) with a Outperform and raises the price target from $1500 to $1600.